EP2493870
Krómenónafleiður með æxliseyðandi virkni
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
25.10.2010EP published:
17.12.2014EP application number:
10769052.1
EP translation filed:
9.2.2015Grant published:
15.3.2015EPO information:
European Patent Register
Max expiry date:
24.10.2030Expiry date:
24.10.2019
Title:
CHROMENONE DERIVATIVES WITH ANTI -TUMOUR ACTIVITY
Timeline
Today
25.10.2010EP application
17.12.2014EP Publication
9.2.2015Translation submitted
15.3.2015Registration published
24.10.2019Expires
Owner
Name:
AstraZeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
BARLAAM, Bernard, ChristopheAddress:
F-51689 Reims Cedex 2, FR
Name:
DEGORCE, Sebastien, LouisAddress:
F-51689 Reims Cedex 2, FR
Name:
LAMBERT-VAN DER BREMPT, Christine, Marie, PaulAddress:
F-51689 Reims Cedex 2, FR
Name:
MORGENTIN, Remy, RobertAddress:
F-51689 Reims Cedex 2, FR
Name:
PLE, PatrickAddress:
F-51689 Reims Cedex 2, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
09306017Date:
27.10.2009Country:
EP
Classification
Categories:
C07D 311/22, A61K 31/5377, A61K 31/558
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 10.9.2015
Expires: 24.10.2016
Payer: Árnason Faktor
Number: 7
Paid: 6.9.2016
Expires: 24.10.2017
Payer: Árnason Faktor
Number: 8
Paid: 11.9.2017
Expires: 24.10.2018
Payer: Árnason Faktor
Number: 9
Paid: 6.9.2018
Expires: 24.10.2019
Payer: Árnason Faktor